COC

DRUG4 trials

Sponsors

GlaxoSmithKline, Takeda, Amgen

Conditions

Bipolar DisorderHealthy VolunteersObesityOverweightSocial Phobia

Phase 1

Oral Contraceptive Interaction Study for GW273225

TerminatedNCT00483535

GlaxoSmithKlineBipolar Disorder

Start: 2007-03-07End: 2007-11-16Updated: 2017-08-08

A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills

TerminatedNCT00508911

GlaxoSmithKlineSocial Phobia

Start: 2007-06-08End: 2007-10-22Updated: 2017-08-04

A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

CompletedNCT06793943

TakedaHealthy Volunteers

Start: 2025-01-23End: 2025-03-30Updated: 2025-04-04

Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity

RecruitingNCT07523711

AmgenObesity, Overweight

Start: 2026-04-09End: 2026-10-07Target: 45Updated: 2026-04-27